Maryland, D.C., and Virginia — one of the largest life science corridors in the U.S.
Explore →
Philadelphia, South Jersey, and Delaware — a powerhouse of pharma and biotech innovation.
Explore →
North Carolina's Research Triangle — a growing hub for biotech and life sciences.
Explore →
Xcellon Biologics, a Maryland CRDMO specializing in bioconjugates and complex biologics, has signed a definitive agreement to acquire the GMP biologics manufacturing facility built by NextCure, Inc. in Beltsville. The deal gives Xcellon its first cGMP capacity, completes the company’s transition from a development-stage CDMO into an end-to-end CRDMO, and puts a commissioned domestic bioconjugation […]
Read More →Wake Tech Community College celebrated 120 future biotechnology professionals on September 23, 2026 at its annual Biotech White Coat Ceremony, where students took a symbolic first step toward careers in one of North Carolina’s fastest-growing industries. Students in Wake Tech’s Biotechnology associate degree programs and BioWork non-degree training program, along with students from Wake Early […]
Atsena Therapeutics, a Durham, NC-based clinical-stage gene therapy company focused on reversing or preventing blindness from inherited retinal disease, presented 18-month safety and efficacy results on September 30, 2026 from Part A of the Phase 1/2/3 LIGHTHOUSE Trial evaluating ATSN-201 in patients with X-linked retinoschisis (XLRS), at the American Academy of Optometry 2026 Annual Meeting […]
The National Center to Accelerate Cures (NCAC) today, October 1, 2026 announced its official launch as a national initiative dedicated to advancing New Approach Methodologies (NAMs) toward regulatory acceptance. The Center is funded by $3 million in congressionally directed funding secured by U.S. Senators (Maryland) Chris Van Hollen and Angela Alsobrooks, and is housed at […]
ATCC, a non-profit biological resource center, has been selected for three new federal contract awards using new approach methodologies (NAMs) to advance nonclinical research across infectious disease and oncology. The awards affirm ATCC’s position as a leader in new approach methodologies (NAMs) and its work to build a trusted infrastructure for nonclinical science through authenticated, […]
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection of the latest news, delivered directly to your inbox weekly. […]
Larimar Therapeutics, a clinical-stage biotechnology company in Bala Cynwyd, Pennsylvania, focused on treatments for complex rare diseases, has appointed John Harlow as President and Chief Operating Officer, effective September 29, 2026. Harlow reports to CEO Carole Ben-Maimon, MD, and brings more than 25 years of commercial, operational, and business development experience in biopharma. “As nomlabofusp […]
Legend Biotech, a global biotechnology company based in New Jersey, has hired Josh Schwartz, MD, MBA as Senior Vice President. Legend develops advanced cell therapies across several technology platforms, including autologous and allogeneic CAR-T and natural killer (NK) cell-based immunotherapies. Schwartz will work on-site at the company’s Bridgewater, New Jersey location. Reflecting on his time […]
Aro Biotherapeutics, a Philadelphia-based clinical-stage biotechnology company developing targeted short-interfering RNA (siRNA) medicines for diseases with high unmet medical need, has appointed Brett Blackman, Ph.D., Senior Vice President, Chief Operating Officer and Chief Business Officer of Valo Health, to its Board of Directors. Blackman brings more than 25 years of experience spanning drug discovery, engineering, […]
GSK, a global biopharma company developing vaccines and specialty medicines, has hired Tyler Reynolds as Director, Digital Medicine. He joins after three years at AstraZeneca and Evinova, where he worked on digital strategy across oncology and cell therapy. In this role he’ll help shape digital strategy for the company’s respiratory, immunology and inflammation portfolio. Tyler […]
